Matches in Wikidata for { <http://www.wikidata.org/entity/Q64676113> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64676113 description "clinical trial" @default.
- Q64676113 description "ensayu clínicu" @default.
- Q64676113 description "klinisch onderzoek" @default.
- Q64676113 description "клінічне випробування" @default.
- Q64676113 name "FACTO Study (Foster® As Complete Treatment Option)" @default.
- Q64676113 type Item @default.
- Q64676113 label "FACTO Study (Foster® As Complete Treatment Option)" @default.
- Q64676113 prefLabel "FACTO Study (Foster® As Complete Treatment Option)" @default.
- Q64676113 P1050 Q64676113-DC4126C5-DA47-4AC9-ABC8-FD7D9E1845E7 @default.
- Q64676113 P1132 Q64676113-C25AB77C-FD3F-4195-A269-1E042F710411 @default.
- Q64676113 P1476 Q64676113-D68CB7E4-AF64-4BA3-843D-8AE558D555E1 @default.
- Q64676113 P17 Q64676113-25DE1A66-138A-40B3-9AD1-6F50BA849BEA @default.
- Q64676113 P17 Q64676113-2E9E62CE-3EDE-4411-9F3C-39E08D005D4A @default.
- Q64676113 P17 Q64676113-EE16FC8F-1263-4710-98E4-368FE6E53AD7 @default.
- Q64676113 P17 Q64676113-EF8EFF66-5AE5-480E-AFAF-E326F2171F65 @default.
- Q64676113 P1813 Q64676113-2A5BD330-BAA2-400D-8306-3EFED57911D6 @default.
- Q64676113 P2899 Q64676113-93A3A452-384C-4F86-AF9C-D846A5A8D51E @default.
- Q64676113 P3098 Q64676113-D9092A36-865D-4A71-8E43-0AB9C3AC361B @default.
- Q64676113 P31 Q64676113-AD838122-191C-4E2D-ACAD-F9F336EF2B82 @default.
- Q64676113 P4135 Q64676113-D9A517C4-6BF5-43CE-82B9-6B07245F0AE6 @default.
- Q64676113 P4844 Q64676113-4F4F8926-9709-43C4-9EEB-20096E13783A @default.
- Q64676113 P4844 Q64676113-A5C81285-85AA-4ED5-8DBC-37E6A18A2BD4 @default.
- Q64676113 P580 Q64676113-EBF49FE1-E1D5-4368-B19C-FFFFB0BA030C @default.
- Q64676113 P582 Q64676113-C0030E8B-C3CE-44BE-98DB-87D541715E6F @default.
- Q64676113 P6099 Q64676113-7797C2BE-346B-4EC7-B65C-9FF355436C1E @default.
- Q64676113 P8363 Q64676113-2E2C3EFA-6E01-477C-B192-CE9EAD1395F1 @default.
- Q64676113 P1050 Q35869 @default.
- Q64676113 P1132 "+431" @default.
- Q64676113 P1476 "A PHASE 4, MULTINATIONAL, MULTICENTRE, DOUBLE BLIND, DOUBLE DUMMY, RANDOMIZED, PARALLEL GROUP, CONTROLLED CLINICAL STUDY OF FIXED COMBINATION BECLOMETHASONE DIPROPIONATE 100 µg PLUS FORMOTEROL FUMARATE 6 µg pMDI WITH HFA-134A PROPELLANT (CHF1535, FOSTER®) VERSUS FLUTICASONE 250 µg PLUS SALMETEROL 50 µg DPI (SERETIDE® DISKUS®) AS MAINTENANCE TREATMENT IN CONTROLLED ASTHMATIC PATIENTS." @default.
- Q64676113 P17 Q142 @default.
- Q64676113 P17 Q183 @default.
- Q64676113 P17 Q29 @default.
- Q64676113 P17 Q55 @default.
- Q64676113 P1813 "FACTO" @default.
- Q64676113 P2899 "+18" @default.
- Q64676113 P3098 "NCT00901368" @default.
- Q64676113 P31 Q30612 @default.
- Q64676113 P4135 "+65" @default.
- Q64676113 P4844 Q27132391 @default.
- Q64676113 P4844 Q27264747 @default.
- Q64676113 P580 "2009-05-01T00:00:00Z" @default.
- Q64676113 P582 "2010-09-01T00:00:00Z" @default.
- Q64676113 P6099 Q42825046 @default.
- Q64676113 P8363 Q78089383 @default.